These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28347533)

  • 1. Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart.
    Barbieri LR; Lourenço-Filho DD; Tavares ER; Carvalho PO; Gutierrez PS; Maranhão RC; Stolf NAG
    Ann Thorac Surg; 2017 Aug; 104(2):577-583. PubMed ID: 28347533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model.
    Fiorelli AI; Lourenço-Filho DD; Tavares ER; Carvalho PO; Marques AF; Gutierrez PS; Maranhão RC; Stolf NAG
    Braz J Med Biol Res; 2017 Aug; 50(10):e6225. PubMed ID: 28832763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.
    Lourenço-Filho DD; Maranhão RC; Méndez-Contreras CA; Tavares ER; Freitas FR; Stolf NA
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1522-8. PubMed ID: 21458008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT; Maranhão RC; Tavares ER; Carvalho PO; Higuchi ML; Mattos FR; Pitta FG; Hatab SA; Kalil-Filho R; Serrano CV
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats.
    Maranhão RC; Guido MC; de Lima AD; Tavares ER; Marques AF; Tavares de Melo MD; Nicolau JC; Salemi VM; Kalil-Filho R
    Int J Nanomedicine; 2017; 12():3767-3784. PubMed ID: 28553113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits.
    Bulgarelli A; Leite AC; Dias AA; Maranhão RC
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):531-9. PubMed ID: 24065615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats.
    Pepineli R; Santana AC; Silva FMO; Tavoni TM; Stolf NAG; Noronha IL; Maranhão RC
    J Pharm Pharmacol; 2021 Jul; 73(8):1092-1100. PubMed ID: 33950246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery.
    Occhiutto ML; Freitas FR; Lima PP; Maranhão RC; Costa VP
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):971-8. PubMed ID: 26962693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.
    Mello SB; Tavares ER; Bulgarelli A; Bonfá E; Maranhão RC
    Int J Nanomedicine; 2013; 8():443-9. PubMed ID: 23439784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.
    Daminelli EN; Martinelli AE; Bulgarelli A; Freitas FR; Maranhão RC
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):433-443. PubMed ID: 27628679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
    Maranhão RC; Tavares ER; Padoveze AF; Valduga CJ; Rodrigues DG; Pereira MD
    Atherosclerosis; 2008 Apr; 197(2):959-66. PubMed ID: 18289548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished cytotoxic gene expression in rat cardiac transplants with low-dose cyclosporine/methotrexate combination therapy.
    Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
    Transplantation; 1994 Jul; 58(2):223-32. PubMed ID: 8042241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.
    Leite AC; Solano TV; Tavares ER; Maranhão RC
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):15-22. PubMed ID: 25672520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
    Rodrigues DG; Maria DA; Fernandes DC; Valduga CJ; Couto RD; Ibañez OC; Maranhão RC
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):565-76. PubMed ID: 15726368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
    Bogossian H; Frommeyer G; Ninios I; Bandorski D; Seyfarth M; Matzaroglou C; Lemke B; Eckardt L; Zarse M; Kafchitsas K
    Cardiovasc Ther; 2016 Aug; 34(4):183-90. PubMed ID: 26924260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
    Esper E; Glagov S; Karp RB; Simonsen KK; Filer SR; Scanu AM; Sand ME
    J Heart Lung Transplant; 1997 Apr; 16(4):420-35. PubMed ID: 9154953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model.
    Meneghini BC; Tavares ER; Guido MC; Tavoni TM; Stefani HA; Kalil-Filho R; Maranhão RC
    Vascul Pharmacol; 2019 Apr; 115():46-54. PubMed ID: 30797043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.